Benign prostatic hyperplasia

Prostate cancer

Henry Woo is a Urological Surgeon sub-specialising in Prostate Surgery. He is an Honorary Professor of Urology at the College of Health and Medicine of the Australian National University.  He is a staff specialist and Head of the Department of Urology at Blacktown Hospital in the Western Sydney Local Health District and was formerly Head of Department and Director of the SAN Prostate Centre of Excellence at the Sydney Adventist Hospital.  He is also Director of Uro-Oncology and Professor of Robotic Cancer Surgery at the Chris O’Brien Lifehouse.

Henry has extensive clinical trials experience in the areas of prostate cancer and benign prostate disease in various capacities ranging from site principal investigator through to trial management committee membership of large funded studies. 

He is on the Board of Directors of the Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group as well as the charitable Australasian Urological Foundation.  He runs a busy clinical trials unit, Australian Clinical Trials (ACT) Pty Ltd and provides opportunity for his patients to access novel treatments under clinical trial evaluation. He has been active member of the Urological Society of Australia New Zealand (USANZ) where he has held a number of senior positions over the years including Chair of the NSW Section, Convenor of the Annual Scientific Meeting and Chair of Continuing Professional Development to name a few.

He is a Fellowship Elected Councillor of the Royal Australasian College of Surgeons and currently serves as the Chair of the Research and Academic Surgery Committee, He has previously served as the Chair of the Australian and New Zealand Scholarships and Grants Committee.

Role of novel imaging in prostate cancer diagnosis and management

Role of minimally invasive surgical treatments for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia